Cargando…
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a particularly challenging tumor type because of its extensive phenotypic variability as well as intra-tumoral heterogeneity (ITH). Clinically, this complexity has been reduced to a handful of pathological variables such as stage, grade and necr...
Autores principales: | Cai, Qi, Christie, Alana, Rajaram, Satwik, Zhou, Qinbo, Araj, Ellen, Chintalapati, Suneetha, Cadeddu, Jeffrey, Margulis, Vitaly, Pedrosa, Ivan, Rakheja, Dinesh, McKay, Renee M., Brugarolas, James, Kapur, Payal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000318/ https://www.ncbi.nlm.nih.gov/pubmed/31859241 http://dx.doi.org/10.1016/j.ebiom.2019.10.052 |
Ejemplares similares
-
Corrigendum to ‘‘Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type’’ [EBioMedicine 51 (2020) 102526]
por: Cai, Qi, et al.
Publicado: (2020) -
What is the role of nephrectomy following complete response to checkpoint inhibitors?
por: Woldu, Solomon L., et al.
Publicado: (2018) -
Determinants of renal cell carcinoma invasion and metastatic competence
por: Kim, Kangsan, et al.
Publicado: (2021) -
Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma
por: Patel, Viral, et al.
Publicado: (2020) -
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
por: Ho, Thai Huu, et al.
Publicado: (2017)